Improving Health for All of Us in Baltimore and Beyond

Are you a Baltimore resident who identifies as African-American/Black, Hispanic, and/or LGBTQIA? Join the University of Maryland School of Nursing for a FREE event to learn more about a National Institutes of Health-funded national research program seeking to gather important health information from 1 million+ people in the United States. The anonymous data will help scientists prevent and treat illnesses for generations to come. FREE light breakfast served at 9 a.m. and lunch served at 12:30 p.m. Learn more: | Questions? Contact Kristen Rawlett at or 410-706-3906.

LGBTQ Forum for MD Gubernatorial Candidates

Join the Gay, Lesbian, Bisexual and Transgender Community Center of Baltimore and Central Maryland & Pride Foundation of Maryland on April 28, 2018 from 4:30-6:30 PM (forum will begin promptly at 4:30 PM, so please arrive early) for an important conversation with the Democratic candidates for Governor of Maryland in the 2018 election. Moderator: Anthony McCarthy The discussion topics will be: -Continued Discrimination Against LGBTQ People in Maryland -Economic Insecurity and Housing Insecurity -LGBTQ Health and Healthcare in Maryland -Criminal Justice and Baltimore’s Federal Consent Decree -Youth in Maryland’s Education System The candidates will be taking questions from the community […]

Aestheics and Injectable Fillers-Are they right for you?

A more youthful and rested look at a reasonable cost with no anesthesia and no need to go under the knife? Is it any wonder that in 2015 nonsurgical cosmetic procedures have increased by over 700% since 2000? That’s according to the American Society for Plastic Surgery. It’s a trend that will likely continue as more of us consider anti-aging alternatives that fall between a facelift and a wrinkle cream.

The Wyden-Grassley US Senate bipartisan Sovaldi Investigation Spotlights a Revenue-Driven Pricing Strategy Behind Gilead’s $1,000 per pill Hepatitis Drug Launch

The US Senate Finance Committee chaired by Senators Ron Wyden, D-Oregon and Chuck Grassley, R-Iowa issued a scathing bipartisan investigative report on December 1, 2015, revealing a clearly intended pricing and marketing strategy undertaken by Gilead Sciences, Inc. with little concern for patient access or availability to its life-saving drug Sovaldi which has a 99% success cure rate for hepatitis C (HCV). The report which took 18 months to complete is amazingly thorough and comprehensive worthy of the US Senate and a Pulitzer Prize for investigative reporting. The full report is available at: A press conference given by Senators […]